97 related articles for article (PubMed ID: 7964055)
1. [Case of malignant histiocytosis treated with chop therapy and splenectomy].
Kitano Y; Nakagawa M; Kojima M; Kumagai H; Tani G; Komatsu M; Nara M; Nakano S; Oyashiki K; Toyama K
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):990-2. PubMed ID: 7964055
[No Abstract] [Full Text] [Related]
2. [Exchange transfusion and combination chemotherapy in the treatment of 4 cases of childhood malignant histiocytosis].
Kizaki Z; Fukumochi H; Sawai T; Ishimura K; Esumi N; Nagai T; Todo S; Imashuku S
Rinsho Ketsueki; 1987 Jun; 28(6):845-51. PubMed ID: 3669324
[No Abstract] [Full Text] [Related]
3. [Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy].
Mori H; Shimizu T; Harada H; Miyoshi Y; Okada S; Takizawa Y; Niikura H; Terada H; Fujita K
Rinsho Ketsueki; 1991 Mar; 32(3):244-9. PubMed ID: 2041166
[TBL] [Abstract][Full Text] [Related]
4. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
5. [Malignant histiocytosis: study of 8 cases].
Fernández Miranda C; Martínez González MA; Ricard P; Ballestín C; Asso A; Hernández Martínez E; Guerra J; del Palacio A
Med Clin (Barc); 1988 Mar; 90(11):437-42. PubMed ID: 2455200
[No Abstract] [Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous histiocytic lesions: a clinical dilemma.
Lahoti NG; Natarajan A; Karuna R; D'Souza RE
J Postgrad Med; 2000; 46(4):275-7. PubMed ID: 11435656
[TBL] [Abstract][Full Text] [Related]
8. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Fisher RI
Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
[No Abstract] [Full Text] [Related]
9. The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Connors JM
Important Adv Oncol; 1990; ():227-33. PubMed ID: 2182521
[No Abstract] [Full Text] [Related]
10. Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine, and prednisone regimen and surgery.
Shinagare AB; Ramaiya NH; Jagannathan JP; Hornick JL; Swanson RS
J Clin Oncol; 2011 Dec; 29(35):e849-51. PubMed ID: 22042944
[No Abstract] [Full Text] [Related]
11. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology].
Tominaga S; Kondo M
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551
[No Abstract] [Full Text] [Related]
12. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
[No Abstract] [Full Text] [Related]
13. [Severe pseudotumoral panniculitis in the child: cytophagic histiocytic panniculitis? Favorable outcome with chemotherapy].
Labeille B; Pautard B; Pare F; Lok C; Gontier MF; Devauchelle B; Delobel J; Denoeux JP
Ann Dermatol Venereol; 1990; 117(11):807-8. PubMed ID: 2099686
[No Abstract] [Full Text] [Related]
14. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of non-Hodgkin's lymphoma with CHOP therapy: analysis of lymphocyte subsets and interleukin 2 activity during CHOP therapy].
Suzuki Y; Yamada H; Saito Y; Nakajima H; Shinozaki T; Isono M; Chikada K; Maeno H; Sawaki S; Yamada K
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1225-31. PubMed ID: 3491170
[No Abstract] [Full Text] [Related]
16. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Takagi T; Sakai C; Oguro M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
[No Abstract] [Full Text] [Related]
17. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.
Miller TP; Jones SE; Rainey JM
Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200
[No Abstract] [Full Text] [Related]
19. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
20. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
